Status:
COMPLETED
Continuous Subcutaneous Insulin Infusion Versus Multiple Dose Insulin Injections in Routine Clinical Practice
Lead Sponsor:
Castilla-La Mancha Health Service
Collaborating Sponsors:
University of Castilla-La Mancha
Universidad de Córdoba
Conditions:
Type 1 Diabetes Mellitus
Eligibility:
All Genders
18+ years
Brief Summary
Observational study about effectiveness and safety of continuous subcutaneous insulin infusion compared to multiple dose insulin injections in Type 1 Diabetes Mellitus (T1DM) adult patients in routine...
Detailed Description
Cross-sectional analysis about effectiveness and safety of continuous subcutaneous insulin infusion compared to multiple dose insulin injections in T1DM adult patients in routine clinical practice. A...
Eligibility Criteria
Inclusion
- ≥18 years of age.
- Diagnosed of Type 1 Diabetes Mellitus.
- Be attended in Ciudad Real General University Hospital.
- Current treated with CSII (CSII cohort) or MDI (MDI cohort) during ≥6 months.
Exclusion
- Less than 18 years old.
- Other types of diabetes mellitus.
Key Trial Info
Start Date :
January 1 2019
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
December 31 2019
Estimated Enrollment :
90 Patients enrolled
Trial Details
Trial ID
NCT03793283
Start Date
January 1 2019
End Date
December 31 2019
Last Update
January 18 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Obispo Rafael Torija, St.
Ciudad Real, Spain, 13005